Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

QUEST DIAGNOSTICS

(DGX)
  Report
Delayed Nyse  -  04:03 2022-10-03 pm EDT
125.44 USD   +2.79%
10/03QUEST DIAGNOSTICS : Ex-dividend day for
FA
09/27Quest Diagnostics to Release Third Quarter 2022 Financial Results on October 20, 2022
PR
09/16FDA Authorizes Quest Diagnostics' Proprietary Monkeypox Test for Emergency Use
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Quest Diagnostics Declares Quarterly Cash Dividend, Payable on October 19, 2022

08/10/2022 | 05:05pm EDT

Quest Diagnostics Incorporated announced that its Board of Directors declared a quarterly cash dividend of $0.66 per share, payable on October 19, 2022 to shareholders of record of Quest Diagnostics common stock on October 4, 2022.


© S&P Capital IQ 2022
All news about QUEST DIAGNOSTICS
10/03QUEST DIAGNOSTICS : Ex-dividend day for
FA
09/27Quest Diagnostics to Release Third Quarter 2022 Financial Results on October 20, 2022
PR
09/16FDA Authorizes Quest Diagnostics' Proprietary Monkeypox Test for Emergency Use
AQ
09/15Quest Diagnostics Teams Up With Lee Health to Deliver High-Value, Innovative Laboratory..
PR
09/15Quest Diagnostics Teams Up with Lee Health to Deliver High-Value, Innovative Laboratory..
CI
09/14Achievers and Quest Diagnostics Win Gold in the 2022 Brandon Hall Group Excellence Tech..
BU
09/13Transcript : Quest Diagnostics Incorporated Presents at Morgan Stanley 20th A..
CI
09/13Quest Diagnostics to Perform Confirmatory Testing of Positive Breath Samples From Hound..
MT
09/13Hound Labs Forms Strategic Agreement with Quest Diagnostics
AQ
09/13Hound Labs Announces Agreement with Quest Diagnostics
CI
More news
Analyst Recommendations on QUEST DIAGNOSTICS
More recommendations
Financials (USD)
Sales 2022 9 692 M - -
Net income 2022 1 028 M - -
Net Debt 2022 3 063 M - -
P/E ratio 2022 14,4x
Yield 2022 2,15%
Capitalization 14 306 M 14 306 M -
EV / Sales 2022 1,79x
EV / Sales 2023 1,87x
Nbr of Employees 44 500
Free-Float 71,7%
Chart QUEST DIAGNOSTICS
Duration : Period :
Quest Diagnostics Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends QUEST DIAGNOSTICS
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Last Close Price 122,69 $
Average target price 143,21 $
Spread / Average Target 16,7%
EPS Revisions
Managers and Directors
Stephen H. Rusckowski Chairman, President & Chief Executive Officer
James E. Davis Senior Vice President-Diagnostics Solutions
Sam A. Samad Chief Financial Officer & Executive Vice President
Jay G. Wohlgemuth Chief Medical Officer, Senior VP-R&D, Medical
Gabrielle Wolfson SVP, Chief Information & Digital Officer
Sector and Competitors